These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 10729137)

  • 1. Evidence for a bidirectional element located downstream from the herpes simplex virus type 1 latency-associated promoter that increases its activity during latency.
    Berthomme H; Lokensgard J; Yang L; Margolis T; Feldman LT
    J Virol; 2000 Apr; 74(8):3613-22. PubMed ID: 10729137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancer and long-term expression functions of herpes simplex virus type 1 latency-associated promoter are both located in the same region.
    Berthomme H; Thomas J; Texier P; Epstein A; Feldman LT
    J Virol; 2001 May; 75(9):4386-93. PubMed ID: 11287587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of the herpes simplex virus type 1 latency-associated regulatory region to drive stable reporter gene expression in the nervous system.
    Lachmann RH; Efstathiou S
    J Virol; 1997 Apr; 71(4):3197-207. PubMed ID: 9060683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes simplex virus type 1 promoter activity during latency establishment, maintenance, and reactivation in primary dorsal root neurons in vitro.
    Arthur JL; Scarpini CG; Connor V; Lachmann RH; Tolkovsky AM; Efstathiou S
    J Virol; 2001 Apr; 75(8):3885-95. PubMed ID: 11264377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regions of the herpes simplex virus type 1 latency-associated transcript that protect cells from apoptosis in vitro and protect neuronal cells in vivo.
    Ahmed M; Lock M; Miller CG; Fraser NW
    J Virol; 2002 Jan; 76(2):717-29. PubMed ID: 11752162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue-specific splicing of the herpes simplex virus type 1 latency-associated transcript (LAT) intron in LAT transgenic mice.
    Gussow AM; Giordani NV; Tran RK; Imai Y; Kwiatkowski DL; Rall GF; Margolis TP; Bloom DC
    J Virol; 2006 Oct; 80(19):9414-23. PubMed ID: 16973547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The latency-associated promoter of herpes simplex virus type 1 requires a region downstream of the transcription start site for long-term expression during latency.
    Lokensgard JR; Berthomme H; Feldman LT
    J Virol; 1997 Sep; 71(9):6714-9. PubMed ID: 9261395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LAT expression during an acute HSV infection in the mouse.
    Jarman RG; Wagner EK; Bloom DC
    Virology; 1999 Sep; 262(2):384-97. PubMed ID: 10502517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the transcription start region of the herpes simplex virus type 1 latency-associated transcript promoter on expression of productively infected neurons in vivo.
    Farrell MJ; Margolis TP; Gomes WA; Feldman LT
    J Virol; 1994 Sep; 68(9):5337-43. PubMed ID: 8057417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term promoter activity during herpes simplex virus latency.
    Lokensgard JR; Bloom DC; Dobson AT; Feldman LT
    J Virol; 1994 Nov; 68(11):7148-58. PubMed ID: 7933097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTCF-dependent chromatin boundary element between the latency-associated transcript and ICP0 promoters in the herpes simplex virus type 1 genome.
    Chen Q; Lin L; Smith S; Huang J; Berger SL; Zhou J
    J Virol; 2007 May; 81(10):5192-201. PubMed ID: 17267480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A non-consensus branch point plays an important role in determining the stability of the 2-kb LAT intron during acute and latent infections of herpes simplex virus type-1.
    Mukerjee R; Kang W; Suri V; Fraser NW
    Virology; 2004 Jul; 324(2):340-9. PubMed ID: 15207620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of beta-galactosidase in neurons of dorsal root ganglia which are latently infected with herpes simplex virus type 1.
    Ecob-Prince MS; Hassan K; Denheen MT; Preston CM
    J Gen Virol; 1995 Jun; 76 ( Pt 6)():1527-32. PubMed ID: 7782783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats.
    Goins WF; Sternberg LR; Croen KD; Krause PR; Hendricks RL; Fink DJ; Straus SE; Levine M; Glorioso JC
    J Virol; 1994 Apr; 68(4):2239-52. PubMed ID: 8139009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term transgene expression in mice infected with a herpes simplex virus type 1 mutant severely impaired for immediate-early gene expression.
    Marshall KR; Lachmann RH; Efstathiou S; Rinaldi A; Preston CM
    J Virol; 2000 Jan; 74(2):956-64. PubMed ID: 10623758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes Simplex Virus 1 MicroRNA miR-H8 Is Dispensable for Latency and Reactivation
    Barrozo ER; Nakayama S; Singh P; Neumann DM; Bloom DC
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33208453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Region of herpes simplex virus type 1 latency-associated transcript sufficient for wild-type spontaneous reactivation promotes cell survival in tissue culture.
    Inman M; Perng GC; Henderson G; Ghiasi H; Nesburn AB; Wechsler SL; Jones C
    J Virol; 2001 Apr; 75(8):3636-46. PubMed ID: 11264353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and maintenance of HSV latent infection is mediated through correct splicing of the LAT primary transcript.
    Kang W; Mukerjee R; Fraser NW
    Virology; 2003 Jul; 312(1):233-44. PubMed ID: 12890636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo deletion analysis of the herpes simplex virus type 1 latency-associated transcript promoter.
    Dobson AT; Margolis TP; Gomes WA; Feldman LT
    J Virol; 1995 Apr; 69(4):2264-70. PubMed ID: 7884873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significantly increased expression of beta-glucuronidase in the central nervous system of mucopolysaccharidosis type VII mice from the latency-associated transcript promoter in a nonpathogenic herpes simplex virus type 1 vector.
    Zhu J; Kang W; Wolfe JH; Fraser NW
    Mol Ther; 2000 Jul; 2(1):82-94. PubMed ID: 10899831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.